Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4

Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling

(2020) Negar Shahini et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium

(2020) Antun Ferenčić et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Role of TLR4 Receptor Complex in the Regulation of the Innate Immune Response by Fibronectin

(2020) Mingzhe Zheng et al.   Cells

Inhibition of MyD88 by LM8 attenuates obesity-induced cardiac injury

(2020) Hui Liu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Ibudilast, a Phosphodiesterase Inhibitor and Toll-Like Receptor-4 Antagonist, Improves Hemorrhagic Shock and Reperfusion-Induced Left Ventricular Dysfunction by Reducing Myocardial Tumor Necrosis Factor α

(2020) Nan-Chun Wu et al.   TRANSPLANTATION PROCEEDINGS

Recent advances in understanding the roles of T cells in pressure overload-induced cardiac hypertrophy and remodeling

(2019) Yuhao Liu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia–reperfusion injury by inhibiting monocyte-mediated inflammation in mice

(2019) Masaki Fujiwara et al.   CARDIOVASCULAR RESEARCH

Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization

(2019) Jinxuan Zhao et al.   CARDIOVASCULAR RESEARCH

Angiotensin II-induced Hypertension and Cardiac Hypertrophy are Differentially Mediated by TLR3- and TLR4-Dependent Pathways

(2019) Madhu V Singh et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states

(2019) Kaveh Rahimi et al.   AUTOIMMUNITY REVIEWS

Myeloid differentiation protein 1 protected myocardial function against high‐fat stimulation induced pathological remodelling

(2019) Cai‐Jie Shen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

C1q/TNF‐related protein‐9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction

(2019) Mingxin Liu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation

(2019) Wenjun Li et al.   JOURNAL OF CLINICAL INVESTIGATION

HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in�vitro via the RAGE/ERK1/2 signaling pathway

(2019) Lei Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Unveiling the Interplay between the TLR4/MD2 Complex and HSP70 in the Human Cardiovascular System: A Computational Approach

(2019) Amanda Almeida de Oliveira et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Tid1‐S attenuates LPS‐induced cardiac hypertrophy and apoptosis through ER‐a mediated modulation of p‐PI3K/p‐Akt signaling cascade

(2019) Chun‐Nun Chao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice

(2019) Nasiruddin Nalban et al.   Cardiovascular Toxicology

Cardiovascular Pleiotropic Effects of Natriuretic Peptides

(2019) Forte et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CaMKII Activity in the Inflammatory Response of Cardiac Diseases

(2019) Maria Rosaria Rusciano et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Blockade of intercellular adhesion molecule-1 prevents angiotensin II-induced hypertension and vascular dysfunction

(2019) Ping-Ping Lang et al.   LABORATORY INVESTIGATION

Loss of MD1 increases vulnerability to ventricular arrhythmia in diet-induced obesity mice via enhanced activation of the TLR4/MyD88/CaMKII signaling pathway

(2019) Wei Shuai et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1+ monocytes

(2019) Qiu-Yue Lin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

TLR (Toll-Like Receptor) 4 Antagonism Prevents Left Ventricular Hypertrophy and Dysfunction Caused by Neonatal Hyperoxia Exposure in Rats

(2019) Muhammad Oneeb Rehman Mian et al.   HYPERTENSION

Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy

(2019) Dinender K. Singla et al.   Cells

Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis

(2018) Qilu Fang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Heparan sulfate potentiates leukocyte adhesion on cardiac fibroblast by enhancing Vcam-1 and Icam-1 expression

(2018) Francisco Olivares-Silva et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Caspase-1 regulates Ang II-induced cardiomyocyte hypertrophy via up-regulation of IL-1β

(2018) Yunlong Bai et al.   BIOSCIENCE REPORTS

The regulation and importance of monocyte chemoattractant protein-1

(2018) Vanessa Bianconi et al.   CURRENT OPINION IN HEMATOLOGY

Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents

(2018) Yao Xu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

LncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93

(2018) Yunwei Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways

(2018) Jun Yang et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Regulation of TLR4 expression mediates the attenuating effect of erythropoietin on inflammation and myocardial fibrosis in rat heart

(2018) Fei Liu et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis

(2018) Bruno K. Podesser et al.   JOURNAL OF HYPERTENSION

Corrigendum to “Role of CaMKII in free fatty acid/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo” [J. Mol. Cell. Cardiol. 109 (2017) 1–16]

(2018) Peng Zhong et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mechanisms of physiological and pathological cardiac hypertrophy

(2018) Michinari Nakamura et al.   Nature Reviews Cardiology

PTEN Inhibitor VO-OHpic Attenuates Inflammatory M1 Macrophages and Cardiac Remodeling in Doxorubicin-Induced Cardiomyopathy

(2018) Taylor A. Johnson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Dimethyl fumarate interferes with MyD88-dependent toll-like receptor signalling pathway in isoproterenol-induced cardiac hypertrophy model

(2018) Asmaa A. Ahmed et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Tumor Necrosis Factor-α in Heart Failure: an Updated Review

(2018) Sarah M. Schumacher et al.   Current Cardiology Reports

Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model

(2018) Ruhui Yang et al.   ATHEROSCLEROSIS

MD1 Deficiency Promotes Infiammatory Atrial Remodeling Induced by High-fat Diet

(2018) Wei Shuai et al.   CANADIAN JOURNAL OF CARDIOLOGY

Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization

(2018) Taizo Kimura et al.   CARDIOVASCULAR RESEARCH

Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure

(2018) Ryousuke Satou et al.   CURRENT HYPERTENSION REPORTS

Loss of MD1 exacerbates myocardial ischemia/reperfusion injury and susceptibility to ventricular arrhythmia

(2018) Xiaobo Jiang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell ActivationNovelty and Significance

(2017) Chao Li et al.   HYPERTENSION

Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer

(2017) Je-Kyung Ryu et al.   IMMUNITY

Hypertension, left ventricular hypertrophy, and sudden cardiac death

(2017) Mohammad Shenasa et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy

(2017) Yuhui Qiao et al.   International Journal of Nanomedicine

Proinflammatory Cytokines Mediate GPCR Dysfunction

(2017) Maradumane L. Mohan et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

CaMKII Activation Promotes Cardiac Electrical Remodeling and Increases the Susceptibility to Arrhythmia Induction in High-fat Diet–Fed Mice With Hyperlipidemia Conditions

(2017) Peng Zhong et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone

(2017) Ana Paula Cremasco Takano et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Isorhamnetin protects against cardiac hypertrophy through blocking PI3K–AKT pathway

(2017) Lu Gao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Extracellular cell stress (heat shock) proteins—immune responses and disease: an overview

(2017) A. Graham Pockley et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2

(2017) Yi Wang et al.   Nature Communications

T cell costimulation blockade blunts pressure overload-induced heart failure

(2017) Marinos Kallikourdis et al.   Nature Communications

Toll-Like Receptor 4 Inhibition Improves Oxidative Stress and Mitochondrial Health in Isoproterenol-Induced Cardiac Hypertrophy in Rats

(2017) Parmeshwar B. Katare et al.   Frontiers in Immunology

Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling

(2017) Xiaojv Xiong et al.   Scientific Reports

Loss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling

(2017) Jianye Peng et al.   Scientific Reports

MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway

(2016) Jibo Han et al.   BASIC RESEARCH IN CARDIOLOGY

mTOR, cardiomyocytes and inflammation in cardiac hypertrophy

(2016) Lifen Xu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and DysfunctionNovelty and Significance

(2016) Lin Zhao et al.   CIRCULATION RESEARCH

Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway

(2016) Wei Gao et al.   ENDOCRINOLOGY

Inhibition of TNF-α–mediated NF-κB Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation

(2016) Futian Tang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target

(2016) M. Obayed Ullah et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)

(2016) Neil A. Turner   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro

(2016) Claudio Humeres et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Physiological and pathological cardiac hypertrophy

(2016) Ippei Shimizu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation

(2016) Pia Boza et al.   MOLECULAR IMMUNOLOGY

HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload

(2016) Hairuo Lin et al.   PLoS One

TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension

(2016) Hong-Bao Li et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The emerging role of Toll-like receptor 4 in myocardial inflammation

(2016) Y Yang et al.   Cell Death & Disease

Modulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice

(2016) Vengadeshprabhu Karuppagounder et al.   PLoS One

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

(2015) Yow Keat Tham et al.   ARCHIVES OF TOXICOLOGY

Compromised MAPK signaling in human diseases: an update

(2015) Eun Kyung Kim et al.   ARCHIVES OF TOXICOLOGY

Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling

(2015) R. A. Frieler et al.   CIRCULATION

Getting to the Heart of the Matter

(2015) Andrew Leask   CIRCULATION RESEARCH

Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart FailureCLINICAL PERSPECTIVE

(2015) Tania Nevers et al.   Circulation-Heart Failure

Postulates for validating TLR4 agonists

(2015) Mateja Manček-Keber et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene ExpressionNovelty and Significance

(2015) Madhu V. Singh et al.   HYPERTENSION

Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4

(2015) Susumu Matsuda et al.   Journal of Atherosclerosis and Thrombosis

Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction

(2015) Li Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure

(2015) Lei Zhang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MD-2 is required for disulfide HMGB1–dependent TLR4 signaling

(2015) Huan Yang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Decreased proportion of Foxp3+CD4+ regulatory T cells contributes to the development of hypertension in genetically hypertensive rats

(2015) Masato Katsuki et al.   JOURNAL OF HYPERTENSION

Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension

(2015) Germán E. González et al.   JOURNAL OF HYPERTENSION

The mammalian target of rapamycin modulates the immunoproteasome system in the heart

(2015) Hong-Mei Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension

(2015) Rahul B Dange et al.   Journal of Neuroinflammation

Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions

(2015) G. Díaz-Araya et al.   PHARMACOLOGICAL RESEARCH

Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress

(2015) Srinivas Sriramula et al.   PLoS One

Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice

(2015) Mayra Trentin-Sonoda et al.   PLoS One

Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation

(2015) Heidi Ehrentraut et al.   PLoS One

Toll-like receptors and hypertension

(2014) Madhu V. Singh et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway

(2014) Xiao Yuan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hypertension, TLR4 activation in brain and cardiac hypertrophy

(2014) J. L. Mehta et al.   CARDIOVASCULAR RESEARCH

Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension

(2014) Rahul B. Dange et al.   CARDIOVASCULAR RESEARCH

CD4 + T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload

(2014) Fanny Laroumanie et al.   CIRCULATION

Angiogenesis and Cardiac Hypertrophy

(2014) Toru Oka et al.   CIRCULATION RESEARCH

Bacillus Calmette-Guerin and TLR4 Agonist Prevent Cardiovascular Hypertrophy and Fibrosis by Regulating Immune Microenvironment

(2014) Y.-Y. Liu et al.   JOURNAL OF IMMUNOLOGY

Toll-Like Receptor Signaling Pathways

(2014) Takumi Kawasaki et al.   Frontiers in Immunology

Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure

(2013) Akira Funayama et al.   CARDIOVASCULAR RESEARCH

Unknown

(2013) Eileen Bauer et al.   MOLECULAR MEDICINE

The Effects of TLR Activation on T-Cell Development and Differentiation

(2012) Bo Jin et al.   Clinical & Developmental Immunology

MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction

(2012) Madhu V. Singh et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice

(2012) N Chin Lai et al.   LABORATORY INVESTIGATION

Role of Toll-like receptors in cardiovascular diseases

(2011) Jesus G. Vallejo   CLINICAL SCIENCE

Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure

(2011) Toshinori Aoyagi et al.   CURRENT PHARMACEUTICAL DESIGN

The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy

(2011) Heidi Ehrentraut et al.   EUROPEAN JOURNAL OF HEART FAILURE

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

(2011) Ulrich Hofmann et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Hypertension augments cardiac Toll-like receptor 4 expression and activity

(2011) Ruth Eißler et al.   HYPERTENSION RESEARCH

Development of β-Amino Alcohol Derivatives That Inhibit Toll-like Receptor 4 Mediated Inflammatory Response as Potential Antiseptics

(2011) Sherry A. Chavez et al.   JOURNAL OF MEDICINAL CHEMISTRY

Is CaMKII a link between inflammation and hypertrophy in heart?

(2011) Madhu V. Singh et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Toll-Like Receptor 4 Stimulation Initiates an Inflammatory Response That Decreases Cardiomyocyte Contractility

(2010) Orna Avlas et al.   ANTIOXIDANTS & REDOX SIGNALING

Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice

(2010) Wen-Feng Cai et al.   CARDIOVASCULAR RESEARCH

Temporal correlation between transcriptional changes and increased synthesis of hyaluronan in experimental cardiac hypertrophy

(2010) Urban Hellman et al.   GENOMICS

Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy

(2010) Sandra B. Haudek et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Pressure-Mediated Hypertrophy and Mechanical Stretch Induces IL-1 Release and Subsequent IGF-1 Generation to Maintain Compensative Hypertrophy by Affecting Akt and JNK Pathways

(2009) Shoken Honsho et al.   CIRCULATION RESEARCH

Partial role of TLR4 as a receptor responding to damage-associated molecular pattern

(2009) Kyung-Mi Lee et al.   IMMUNOLOGY LETTERS

Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart

(2009) Madhu V. Singh et al.   JOURNAL OF CLINICAL INVESTIGATION

MyD88-dependent nuclear factor-κB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes

(2009) Ting Li et al.   JOURNAL OF HYPERTENSION

TLR4/MyD88/PI3K interactions regulate TLR4 signaling

(2009) Michelle H. W. Laird et al.   JOURNAL OF LEUKOCYTE BIOLOGY

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

(2008) Anthony J. Muslin   CLINICAL SCIENCE

Functional Toll-like receptor 4 mutations modulate the response to fibrinogen

(2008) Kunal Patel et al.   THROMBOSIS AND HAEMOSTASIS

Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κB

(2007) Sudhiranjan Gupta et al.   JOURNAL OF MOLECULAR BIOLOGY